Contact: Esam Z. Dajani, PhD., FACG(786) 425-2209

NOTED IDDC SCIENTIST SAYS EUROPEAN JOURNAL OF MEDICAL RESEARCH STUDY SUPPORTS OXYGEN ABSORPTION FROM THE STOMACH FOLLOWING THE CONSUMPTION OF SUPEROXYGENATED WATER. - - - - Peer-Reviewed Study Supports The Transport Of Oxygen Via Oxygen-Enriched Water From The Stomach Into the Portal Vein

Nationally acclaimed scientist, Esam Z. Dajani, Ph.D., FACG, today commented on a study published by the European Journal of Medical Research, which examined the pharmacology of SuperOxygenated water. This peer-reviewed study was performed by Drs. Forth and Adam of the Walther-Straub Institute for Pharmacology and Toxicology, Munich, Germany.
...
"The kinetics of oxygen transport in the rabbit is expected to be similar to other mammalian species, including man," said Dr. Dajani, president of IDDC Corporation, a Contract Research Organization (CRO). "The fact that a dose-dependent and a statistically significant increase in pO2 value was present in the abdominal cavity and portal vein following the intragastric administration of oxygenated water indicates that oxygen is readily transported from the stomach and gastrointestinal tract to the systemic circulation and presumably muscle tissues."

"Increased oxygen concentration in skeletal muscle would provide the needed fuel for the enhancement of athletic performance," Dr. Dajani added. "Furthermore, the increased oxygen concentration into the portal vein could be of benefit for the treatment of inflammatory liver diseases." Dr. Dajani cautioned this would have to be further investigated in prospective laboratory and clinical studies.

Dr. Dajani said this recent study coupled with two independent studies performed by John J. Duncan, Ph.D., Texas Woman's University, and John Seifert, Ph.D., St. Cloud State University underscores the value and benefit of super oxygenated water toward increased athletic performance.
...
Dr. Dajani said that "all three studies suggest that the oxygen made available from the ingestion of oxygenated water can be transported from the stomach and the small bowel to the blood circulation, where it would then directly provide the energy needed by the working muscles rather than having to depend on the metabolic breakdown of glycogen and glucose for the generation of such energy.
...
Esam Z. Dajani, Ph.D., FACG, is an independent consultant who has been retained by BEVsystems International, Inc. to support the clinical development of Super Oxygenated Water. Dr. Dajani is a graduate pharmacologist (Ph.D. in 1969) and a licensed pharmacist (BS in 1963) with 33 years experience in pharmaceutical research and development (R&D). Dr. Dajani is currently the founder and president of the IDDC Corporation, a contract Research Organization (CRO) established in 1993, which provides consulting and drug development services essential for the successful introduction of drugs and biological substances. Dr. Dajani had previously directed worldwide clinical research at Searle Laboratories (currently Pharmacia), Skokie, Illinois and had previously worked at Searle, in various capacities, performing pre-clinical and clinical R&D functions. Dr. Dajani has significant experience in regulatory affairs. Dr. Dajani was most instrumental in the discovery and development of Cytotec, an anti-ulcer prostaglandin drug. Dr. Dajani currently holds Adjunct Professor of Medicine appointment at Loyola University of Chicago. He previously held Adjunct Professor of Pharmacology appointment at Chicago Medical School.

Dr. Dajani published 114 peer-reviewed articles, book chapters and patents covering the fields of pharmacology, gastroenterology and drug development. He also made 126 presentations at national and international biomedical conferences. Dr. Dajani is a member of the editorial boards for the Journal of the Association for Academic Minority Physicians, Journal of Physiology and Pharmacology and Journal of Drug Development Research. Major professional memberships held by Dr. Dajani include: American Society for Pharmacology and Experimental Therapeutics, American Gastroenterological Association, American College of Gastroenterology (Fellow), Association for Academic Minority Physicians (Councilor and Board member), Drug Information Association, American Pharmaceutical Association and Chicago Biotech Network (Founder and Board Member). Dr. Dajani was awarded the Monsanto Corporation Edgar M. Queeny award for outstanding scientific achievement and was named by Purdue University School of Pharmacy and Pharmacal Sciences as a Distinguished Alumnus.